Theseus Pharmaceuticals Q1 EPS $(0.34) Beats $(0.42) Estimate; $243.6M Of Cash, Cash Equivalents, And Marketable Securities, With Runway Projected Into Q3 2025

Benzinga · 05/11/2023 07:23
Theseus Pharmaceuticals (NASDAQ:THRX) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.42) by 19.05 percent. This is a 25.93 percent decrease over losses of $(0.27) per share from the same period last year.